Analystreport

Eyepoint Pharmaceuticals Inc (NASDAQ: EYPT) is now covered by analysts at Laidlaw. They set a "buy" rating and a $5.00 price target on the stock.

EyePoint Pharmaceuticals, Inc.  (EYPT) 
Last eyepoint pharmaceuticals, inc. earnings: 3/5 07:00 am Check Earnings Report